ERYTECH announces the approval of the merger with Pherecydes and reports the results of the Combined Shareholder’s Meeting held on June 23, 2023
23 juin 2023 16h30 HE
|
Erytech Pharma S.A.
ERYTECH announces the approval of the merger with Pherecydes and reports the results of the Combined Shareholder’s Meeting held on June 23, 2023 All resolutions voted with a large...
ERYTECH annonce qu'Akkadian poursuit sa tentative de déstabilisation avec l'introduction d'une nouvelle action judiciaire
20 juin 2023 16h05 HE
|
Erytech Pharma S.A.
COMMUNIQUÉ DE PRESSE ERYTECH annonce qu'Akkadian poursuit sa tentative de déstabilisation avec l'introduction d'une nouvelle action judiciaire Lyon (France), le 20 juin 2023 – ERYTECH Pharma...
ERYTECH announces that Akkadian is continuing its attempt at destabilization with the filing of a new lawsuit
20 juin 2023 16h05 HE
|
Erytech Pharma S.A.
ERYTECH announces that Akkadian is continuing its attempt at destabilization with the filing of a new lawsuit Cambridge, MA (U.S.) and Lyon (France), June 20, 2023 – ERYTECH Pharma (Euronext Paris...
ERYTECH annonce que le tribunal de commerce a débouté Akkadian de sa demande de report du vote sur la fusion avec Pherecydes Pharma
14 juin 2023 14h00 HE
|
Erytech Pharma S.A.
COMMUNIQUÉ DE PRESSE ERYTECH annonce que le tribunal de commerce a débouté Akkadian de sa demande de report du vote sur la fusion avec Pherecydes Pharma Lyon (France), le 14 juin 2023 –...
ERYTECH announces that the Commercial Court has rejected Akkadian's request to postpone the vote on the merger with Pherecydes Pharma
14 juin 2023 14h00 HE
|
Erytech Pharma S.A.
ERYTECH announces that the Commercial Court has rejected Akkadian's request to postpone the vote on the merger with Pherecydes Pharma Cambridge, MA (U.S.) and Lyon (France), June 14, 2023, 8:00...
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 mai 2023
13 juin 2023 12h00 HE
|
Erytech Pharma S.A.
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 mai 2023 Article 223-16 du Règlement Général de l’Autorité des Marchés...
Monthly information related to total number of voting rights and shares composing the share capital _May 31, 2023
13 juin 2023 12h00 HE
|
Erytech Pharma S.A.
Monthly information related to total number of voting rights and shares composing the share capital _May 31, 2023. Article 223-16 of general regulation of French Autorité des...
ERYTECH répond à la désinformation d’Akkadian
12 juin 2023 01h00 HE
|
Erytech Pharma S.A.
COMMUNIQUÉ DE PRESSE ERYTECH répond à la désinformation d’Akkadian La contestation de la fusion par Akkadian est fondée sur des informations incomplètes et des arguments...
ERYTECH Responds to Akkadian’s Disinformation
12 juin 2023 01h00 HE
|
Erytech Pharma S.A.
ERYTECH Responds to Akkadian’s Disinformation Akkadian’s challenge of the merger is based on incomplete information and misleading argumentsAkkadian has not presented any valuable...
ERYTECH announces that Akkadian has initiated proceedings to postpone the vote on the merger with Pherecydes
05 juin 2023 02h00 HE
|
Erytech Pharma S.A.
ERYTECH announces that Akkadian has initiated proceedings to postpone the vote on the merger with Pherecydes Cambridge, MA (U.S.) and Lyon (France), June 5, 2023 – ERYTECH Pharma (Nasdaq &...